USTEKINUMAB

USTEKINUMAB was reported 103163 times

USTEKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 414 0.6198
1 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
2 RHEUMATIC FEVER 2543 0.5699
3 LUPUS VULGARIS 682 0.5413
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
5 C-REACTIVE PROTEIN 492 0.5307
6 RHEUMATOID FACTOR POSITIVE 2982 0.5157
7 SWOLLEN JOINT COUNT 128 0.5120
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
9 GRIP STRENGTH 113 0.4934
10 RED BLOOD CELL SEDIMENTATION RATE 127 0.4552
11 FACET JOINT SYNDROME 1431 0.4391
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4257
13 DUODENAL ULCER PERFORATION 3156 0.4240
14 X-RAY ABNORMAL 735 0.4106
15 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 216 0.3850
16 RETINITIS 661 0.3823
17 DISLOCATION OF VERTEBRA 838 0.3671
18 ILEOCAECAL RESECTION 121 0.3517
19 NEUROLOGIC NEGLECT SYNDROME 178 0.3201
20 HELICOBACTER INFECTION 3256 0.3165
21 PEMPHIGUS 3944 0.3151
22 HAND DEFORMITY 4061 0.3093
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 32 0.3048
24 C-REACTIVE PROTEIN ABNORMAL 1788 0.2785
25 MUSCLE INJURY 2219 0.2675
26 PERIPHERAL VENOUS DISEASE 1080 0.2642
27 SERONEGATIVE ARTHRITIS 298 0.2600
28 SYNOVITIS 4640 0.2571
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1654 0.2544
30 FOLLICULITIS 2611 0.2487
31 PERICARDITIS 3879 0.2306
32 CONTRAINDICATION TO VACCINATION 42 0.2199
33 BONE EROSION 777 0.2195
34 ILEECTOMY 72 0.2136
35 CAROTID ARTERY THROMBOSIS 181 0.2132
36 HYPOCHOLESTEROLAEMIA 65 0.1841
37 GLOSSODYNIA 4074 0.1818
38 PROCTOCOLECTOMY 55 0.1803
39 GRANULOMA SKIN 143 0.1742
40 ENTHESOPATHY 272 0.1738
41 DRUG TOLERANCE DECREASED 472 0.1679
42 PORPHYRIA ACUTE 236 0.1645
43 BREAST CANCER STAGE III 1042 0.1607
44 LIP DRY 1461 0.1607
45 OVERLAP SYNDROME 106 0.1514
46 WOUND 4230 0.1512
47 HYPERCHOLESTEROLAEMIA 1353 0.1400
48 JOINT RANGE OF MOTION DECREASED 1828 0.1362
49 ADJUSTMENT DISORDER 176 0.1354
50 WOUND INFECTION 1475 0.1346
51 TERMINAL ILEITIS 82 0.1336
52 GRIP STRENGTH DECREASED 1175 0.1334
53 SYRINGE ISSUE 2296 0.1311
54 INTESTINAL ANASTOMOSIS 84 0.1304
55 ONYCHOMADESIS 525 0.1250
56 PUSTULAR PSORIASIS 421 0.1225
57 ANASTOMOTIC STENOSIS 45 0.1210
58 SYSTEMIC LUPUS ERYTHEMATOSUS 4292 0.1208
59 IRRITABLE BOWEL SYNDROME 2550 0.1188
60 FAECAL CALPROTECTIN ABNORMAL 48 0.1157
61 DEATH NEONATAL 155 0.1114
62 BURSITIS 1347 0.1109
63 AUTOIMMUNE DISORDER 1078 0.1105
64 LIVE BIRTH 922 0.1101
65 PSORIATIC ARTHROPATHY 4412 0.1086
66 BLOOD PARATHYROID HORMONE DECREASED 158 0.1065
67 ERYTHRODERMIC PSORIASIS 85 0.1032
68 ARTHRITIS ENTEROPATHIC 33 0.1012
69 FIBROMYALGIA 2432 0.0999
70 BLEPHAROSPASM 615 0.0976
71 TENOSYNOVITIS 267 0.0967
72 CONTRAINDICATED PRODUCT ADMINISTERED 2912 0.0961
73 INTESTINAL RESECTION 512 0.0951
74 LOWER RESPIRATORY TRACT INFECTION 4252 0.0934
75 JOINT ANKYLOSIS 53 0.0933
76 ONYCHOMYCOSIS 403 0.0918
77 ILEAL STENOSIS 157 0.0883
78 EXOSTOSIS 804 0.0880
79 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
80 SMALL INTESTINAL RESECTION 102 0.0875
81 LUPUS-LIKE SYNDROME 783 0.0863
82 TYPE 2 DIABETES MELLITUS 2906 0.0862
83 INFECTED FISTULA 46 0.0858
84 LIVER INJURY 2101 0.0855
85 ILEOSTOMY 209 0.0818
86 IMPAIRED HEALING 2665 0.0811
87 DEVICE DEFECTIVE 1398 0.0806
88 LATENT TUBERCULOSIS 168 0.0802
89 THERAPEUTIC PRODUCT EFFECT DECREASED 3549 0.0792
90 SCIATICA 1263 0.0791
91 INFUSION RELATED REACTION 5233 0.0789
92 FINGER DEFORMITY 373 0.0769
93 RED BLOOD CELL SEDIMENTATION RATE INCREASED 847 0.0765
94 POSTOPERATIVE ABSCESS 51 0.0761
95 OBESITY 1178 0.0739
96 ARTHROPATHY 4075 0.0732
97 ANAL STENOSIS 39 0.0732
98 ANAL ABSCESS 392 0.0727
99 NEEDLE ISSUE 2117 0.0726
100 FAECAL CALPROTECTIN INCREASED 229 0.0722
101 HIP ARTHROPLASTY 1088 0.0710
102 NAIL DISORDER 619 0.0707
103 PANNICULITIS 171 0.0706
104 WALKING AID USER 461 0.0698
105 RECTAL ABSCESS 116 0.0691
106 JOINT DISLOCATION 726 0.0686
107 PERSONALITY DISORDER 178 0.0679
108 PRODUCT LEAKAGE 379 0.0675
109 HEPATIC ENZYME INCREASED 4531 0.0664
110 COLECTOMY TOTAL 37 0.0663
111 GUTTATE PSORIASIS 53 0.0646
112 ILEAL ULCER 65 0.0642
113 FOOT DEFORMITY 709 0.0639
114 PULMONARY FIBROSIS 1212 0.0631
115 MATERNAL EXPOSURE TIMING UNSPECIFIED 237 0.0630
116 SPONDYLITIS 229 0.0629
117 LOWER LIMB FRACTURE 1188 0.0618
118 COLECTOMY 346 0.0612
119 RHEUMATOID NODULE 165 0.0598
120 LARGE INTESTINAL STENOSIS 119 0.0595
121 DEVICE DEPLOYMENT ISSUE 751 0.0587
122 PRESCRIBED OVERDOSE 1108 0.0572
123 BLOOD CHOLESTEROL INCREASED 2655 0.0569
124 DISCOMFORT 3457 0.0566
125 INTESTINAL STENOSIS 236 0.0559
126 CUTANEOUS T-CELL LYMPHOMA 70 0.0556
127 ABSCESS INTESTINAL 119 0.0552
128 DRUG SPECIFIC ANTIBODY 75 0.0547
129 SACROILIITIS 103 0.0545
130 PRODUCT LABEL CONFUSION 317 0.0543
131 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 127 0.0535
132 BLISTER 2918 0.0519
133 BREAST CANCER STAGE II 426 0.0512
134 INTESTINAL OPERATION 81 0.0511
135 PYODERMA GANGRENOSUM 183 0.0508
136 PSORIASIS 6617 0.0506
137 KNEE ARTHROPLASTY 1062 0.0504
138 ANAL FISTULA 269 0.0504
139 HEPATIC CIRRHOSIS 942 0.0501
140 DACTYLITIS 49 0.0499
141 GAIT INABILITY 1659 0.0496
142 RASH VESICULAR 240 0.0496
143 GROIN ABSCESS 58 0.0492
144 INFUSION SITE REACTION 147 0.0492
145 STOMA CREATION 34 0.0490
146 ENTEROCUTANEOUS FISTULA 43 0.0488
147 EYE INJURY 148 0.0487
148 TREATMENT FAILURE 3934 0.0474
149 STENOSIS 89 0.0473
150 SMALL INTESTINAL STENOSIS 50 0.0469
151 INTESTINAL FISTULA 66 0.0468
152 BACK INJURY 507 0.0466
153 OSTEOARTHRITIS 1966 0.0463
154 RHEUMATOID LUNG 44 0.0461
155 ULCER HAEMORRHAGE 312 0.0461
156 DRUG INTOLERANCE 4327 0.0447
157 PERFORATION 36 0.0447
158 STOMATITIS 2693 0.0444
159 NIGHT SWEATS 1406 0.0436
160 SWELLING 4068 0.0434
161 RHEUMATOID ARTHRITIS 4920 0.0433
162 CHOLANGITIS SCLEROSING 89 0.0433
163 C-REACTIVE PROTEIN INCREASED 1576 0.0433
164 PRODUCT OUTER PACKAGING ISSUE 39 0.0431
165 PRESCRIBED UNDERDOSE 833 0.0417
166 LIVER FUNCTION TEST INCREASED 888 0.0413
167 INFLAMMATION 2102 0.0407
168 GASTROENTERITIS NOROVIRUS 54 0.0406
169 MOBILITY DECREASED 2916 0.0405
170 JOINT SWELLING 4794 0.0397
171 POUCHITIS 34 0.0395
172 LOSS OF THERAPEUTIC RESPONSE 126 0.0395
173 TUBERCULIN TEST POSITIVE 100 0.0395
174 BONE CYST 37 0.0394
175 INJURY 2753 0.0391
176 ABDOMINAL ABSCESS 172 0.0389
177 GASTROINTESTINAL WALL THICKENING 58 0.0387
178 DRUG DELIVERY SYSTEM MALFUNCTION 197 0.0385
179 SUSPECTED OFF LABEL USE 173 0.0383
180 FISTULA 428 0.0380
181 FISTULA DISCHARGE 48 0.0380
182 COELIAC DISEASE 370 0.0377
183 CONGENITAL ANOMALY 290 0.0374
184 MUSCULOSKELETAL STIFFNESS 3253 0.0371
185 EXPOSURE DURING PREGNANCY 2299 0.0370
186 BASAL CELL CARCINOMA 571 0.0366
187 DRUG LEVEL DECREASED 372 0.0365
188 INJECTION RELATED REACTION 60 0.0363
189 WHEEZING 2139 0.0360
190 THERAPY NON-RESPONDER 1580 0.0351
191 GENERAL PHYSICAL HEALTH DETERIORATION 4045 0.0349
192 PRODUCT DOSE OMISSION ISSUE 10242 0.0348
193 MALIGNANT MELANOMA IN SITU 43 0.0347
194 COLOSTOMY 68 0.0346
195 SPINAL FUSION SURGERY 140 0.0345
196 ROAD TRAFFIC ACCIDENT 1441 0.0344
197 PROSTATE INFECTION 33 0.0343
198 INFECTED CYST 41 0.0342
199 ADENOCARCINOMA OF COLON 64 0.0341
200 COLITIS ULCERATIVE 1516 0.0339
201 ILL-DEFINED DISORDER 2058 0.0338
202 LIQUID PRODUCT PHYSICAL ISSUE 247 0.0338
203 DERMATITIS PSORIASIFORM 69 0.0337
204 GASTROINTESTINAL STOMA COMPLICATION 53 0.0337
205 ABSCESS 534 0.0334
206 MATERNAL EXPOSURE DURING PREGNANCY 2979 0.0334
207 PERTUSSIS 34 0.0326
208 SKIN NECROSIS 169 0.0325
209 INTESTINAL ULCER 51 0.0321
210 LIVER DISORDER 1420 0.0320
211 TONGUE DISORDER 230 0.0318
212 GANGRENE 191 0.0317
213 JOINT STIFFNESS 831 0.0316
214 SQUAMOUS CELL CARCINOMA 298 0.0316
215 OEDEMA 1711 0.0315
216 VEIN RUPTURE 52 0.0310
217 DRUG TOLERANCE 156 0.0308
218 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 71 0.0308
219 FREQUENT BOWEL MOVEMENTS 829 0.0307
220 DRUG LEVEL BELOW THERAPEUTIC 168 0.0304
221 GASTROINTESTINAL BACTERIAL INFECTION 34 0.0297
222 LUNG DISORDER 1451 0.0296
223 SLEEP DISORDER 2068 0.0293
224 PRODUCT USE ISSUE 5463 0.0290
225 EAR INFECTION 772 0.0290
226 SINUSITIS 2948 0.0287
227 GENERAL SYMPTOM 215 0.0287
228 GASTROINTESTINAL DISORDER 2530 0.0282
229 POSTOPERATIVE WOUND INFECTION 190 0.0281
230 CERVICAL DYSPLASIA 61 0.0279
231 INTESTINAL DILATATION 37 0.0277
232 PRODUCT LABEL ISSUE 187 0.0275
233 DRUG-INDUCED LIVER INJURY 861 0.0274
234 SENSORY LOSS 219 0.0272
235 JOINT DESTRUCTION 42 0.0270
236 FEMALE GENITAL TRACT FISTULA 46 0.0269
237 INFLAMMATORY BOWEL DISEASE 260 0.0265
238 MYOSITIS 238 0.0265
239 INTENTIONAL PRODUCT USE ISSUE 2317 0.0264
240 TOOTH ABSCESS 269 0.0264
241 DELIRIUM 909 0.0262
242 ABDOMINAL DISCOMFORT 4383 0.0261
243 NORMAL NEWBORN 142 0.0261
244 TASTE DISORDER 527 0.0260
245 ADVERSE REACTION 343 0.0258
246 MUSCULOSKELETAL PAIN 1354 0.0258
247 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 443 0.0258
248 PREGNANCY 515 0.0257
249 PRODUCT DOSE OMISSION 1671 0.0256
250 HYPERSENSITIVITY 4733 0.0255
251 TONSILLITIS 133 0.0255
252 SUBCUTANEOUS ABSCESS 122 0.0254
253 DISABILITY 503 0.0254
254 DRUG ERUPTION 450 0.0254
255 MUCOUS STOOLS 125 0.0252
256 GASTROINTESTINAL INFLAMMATION 196 0.0250
257 INFECTION 3583 0.0247
258 DERMATITIS EXFOLIATIVE GENERALISED 86 0.0247
259 SKIN PLAQUE 206 0.0244
260 PRODUCT PACKAGING ISSUE 232 0.0244
261 THERAPEUTIC RESPONSE DECREASED 1469 0.0242
262 LARGE INTESTINAL ULCER 65 0.0239
263 PROCTITIS 67 0.0239
264 CLOSTRIDIUM DIFFICILE INFECTION 519 0.0238
265 EPILEPSY 720 0.0235
266 ALOPECIA 4614 0.0235
267 MUSCLE SPASTICITY 287 0.0233
268 HEMIPLEGIA 194 0.0233
269 ARTERIAL OCCLUSIVE DISEASE 183 0.0233
270 INCORRECT PRODUCT STORAGE 304 0.0231
271 SINUS CONGESTION 310 0.0229
272 DEVICE ISSUE 2015 0.0224
273 PAPILLOMA VIRAL INFECTION 37 0.0224
274 DRUG SPECIFIC ANTIBODY PRESENT 145 0.0223
275 CHOLANGIOCARCINOMA 33 0.0221
276 SALMONELLOSIS 37 0.0219
277 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1557 0.0219
278 GASTROINTESTINAL INFECTION 195 0.0217
279 ARTHRITIS 1711 0.0217
280 POST PROCEDURAL INFECTION 176 0.0216
281 HEPATIC FIBROSIS 74 0.0215
282 IGA NEPHROPATHY 35 0.0211
283 ENTERITIS 135 0.0211
284 SKIN HAEMORRHAGE 310 0.0209
285 CONTUSION 1996 0.0207
286 INVASIVE DUCTAL BREAST CARCINOMA 56 0.0206
287 GRANULOMA 71 0.0205
288 ERYSIPELAS 102 0.0203
289 DRY MOUTH 1646 0.0203
290 NASOPHARYNGITIS 3726 0.0202
291 OSTEOPOROSIS 825 0.0200
292 KIDNEY INFECTION 393 0.0200
293 PRODUCT CONTAINER SEAL ISSUE 34 0.0195
294 AFFECT LABILITY 188 0.0195
295 SMALL INTESTINAL OBSTRUCTION 239 0.0194
296 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 926 0.0193
297 ANORECTAL DISORDER 38 0.0190
298 TENDONITIS 295 0.0190
299 VITAMIN B12 DEFICIENCY 76 0.0188
300 SUBILEUS 39 0.0187
301 PERIPHERAL SWELLING 2885 0.0187
302 CYTOMEGALOVIRUS COLITIS 43 0.0187
303 MOTOR DYSFUNCTION 190 0.0186
304 ADVERSE EVENT 1717 0.0186
305 URTICARIA 3120 0.0186
306 MALIGNANT MELANOMA 247 0.0184
307 ABDOMINAL INFECTION 47 0.0184
308 VARICELLA ZOSTER VIRUS INFECTION 38 0.0183
309 ABSCESS LIMB 78 0.0183
310 WEIGHT FLUCTUATION 191 0.0182
311 HYPOAESTHESIA 2708 0.0181
312 DEFAECATION URGENCY 126 0.0180
313 JOINT ARTHROPLASTY 32 0.0179
314 HIDRADENITIS 163 0.0179
315 SELF-MEDICATION 73 0.0177
316 CELLULITIS 885 0.0175
317 ANTINUCLEAR ANTIBODY POSITIVE 57 0.0175
318 ULCER 279 0.0175
319 CONDITION AGGRAVATED 5316 0.0175
320 POLYARTHRITIS 92 0.0174
321 ADVERSE DRUG REACTION 1560 0.0174
322 UPPER RESPIRATORY TRACT INFECTION 798 0.0173
323 FEAR OF INJECTION 123 0.0172
324 SKIN INJURY 57 0.0172
325 MIGRAINE 1639 0.0172
326 OSTEOLYSIS 35 0.0171
327 SKIN INFECTION 192 0.0171
328 RHEUMATIC DISORDER 33 0.0171
329 DYSPEPSIA 1668 0.0169
330 CONFUSIONAL STATE 2714 0.0168
331 GASTROINTESTINAL OBSTRUCTION 40 0.0166
332 INTESTINAL OBSTRUCTION 625 0.0166
333 EAR PAIN 318 0.0163
334 HEPATITIS 417 0.0163
335 OBSTRUCTION 65 0.0163
336 ERYTHEMA NODOSUM 57 0.0162
337 HYPERTENSION 3412 0.0161
338 DYSCHEZIA 49 0.0160
339 ANAL FISSURE 86 0.0160
340 RENAL NEOPLASM 34 0.0160
341 GASTRIC INFECTION 61 0.0159
342 DIARRHOEA HAEMORRHAGIC 149 0.0159
343 PRODUCT STORAGE ERROR 1386 0.0158
344 EXPOSURE VIA BREAST MILK 63 0.0158
345 HEPATIC STEATOSIS 294 0.0158
346 DEMYELINATION 64 0.0156
347 SUSPECTED COVID-19 51 0.0154
348 UNDERDOSE 1128 0.0154
349 VITILIGO 36 0.0153
350 BACK DISORDER 247 0.0152
351 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2726 0.0151
352 VARICELLA 36 0.0151
353 LYME DISEASE 50 0.0150
354 SKIN PAPILLOMA 60 0.0149
355 ADENOCARCINOMA 33 0.0147
356 OFF LABEL USE 12880 0.0147
357 RECTAL CANCER 45 0.0146
358 AMNESIA 949 0.0146
359 INFLAMMATORY MARKER INCREASED 72 0.0145
360 FACIAL PARALYSIS 123 0.0144
361 ACCIDENTAL EXPOSURE TO PRODUCT 1479 0.0143
362 ARTHRALGIA 5902 0.0142
363 WEIGHT INCREASED 3177 0.0142
364 RESPIRATORY DISORDER 422 0.0141
365 RESPIRATORY TRACT CONGESTION 223 0.0140
366 APPENDICITIS 131 0.0140
367 DENGUE FEVER 32 0.0139
368 PUSTULE 33 0.0139
369 HAEMATOCHEZIA 763 0.0138
370 SINUS DISORDER 272 0.0137
371 LUNG ADENOCARCINOMA 41 0.0136
372 PNEUMONIA 4394 0.0136
373 COORDINATION ABNORMAL 189 0.0135
374 RESPIRATORY TRACT INFECTION 351 0.0135
375 HYPERCALCAEMIA 166 0.0134
376 CUSHINGOID 43 0.0134
377 GUILLAIN-BARRE SYNDROME 64 0.0132
378 RASH 5714 0.0131
379 CHOLECYSTITIS INFECTIVE 36 0.0130
380 SURGERY 750 0.0128
381 DERMATITIS EXFOLIATIVE 64 0.0128
382 MUSCULAR WEAKNESS 1444 0.0127
383 APPENDICECTOMY 45 0.0126
384 RECTAL HAEMORRHAGE 536 0.0125
385 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 208 0.0122
386 CYSTITIS 389 0.0122
387 SKIN CANCER 263 0.0122
388 ASTHMA 1377 0.0122
389 APHTHOUS ULCER 94 0.0121
390 STREPTOCOCCAL INFECTION 67 0.0120
391 DRUG DOSE OMISSION 1984 0.0120
392 COLITIS 453 0.0119
393 VARICES OESOPHAGEAL 36 0.0119
394 PHARYNGITIS 147 0.0118
395 RASH PUSTULAR 86 0.0118
396 SQUAMOUS CELL CARCINOMA OF SKIN 71 0.0117
397 IRON DEFICIENCY ANAEMIA 108 0.0117
398 PROCTALGIA 75 0.0117
399 ABDOMINAL PAIN UPPER 2398 0.0116
400 HYPERTRANSAMINASAEMIA 81 0.0116
401 HEMIPARESIS 196 0.0116
402 LOCALISED INFECTION 279 0.0115
403 CUTANEOUS VASCULITIS 42 0.0115
404 INTESTINAL PERFORATION 129 0.0115
405 ABDOMINAL PAIN 2649 0.0114
406 DRUG INEFFECTIVE 14942 0.0113
407 SKIN ULCER 293 0.0113
408 PLANTAR FASCIITIS 38 0.0113
409 NECK PAIN 633 0.0113
410 MEDICATION ERROR 626 0.0113
411 CLOSTRIDIAL INFECTION 38 0.0112
412 FUNCTIONAL GASTROINTESTINAL DISORDER 38 0.0110
413 MELANOCYTIC NAEVUS 48 0.0109
414 CHEMOTHERAPY 41 0.0108
415 DIVERTICULITIS 300 0.0108
416 EATING DISORDER 230 0.0108
417 WOUND COMPLICATION 37 0.0108
418 HYSTERECTOMY 93 0.0107
419 MEMORY IMPAIRMENT 1475 0.0107
420 SNEEZING 240 0.0107
421 UVEITIS 145 0.0107
422 IRON DEFICIENCY 48 0.0107
423 THERAPY CHANGE 104 0.0106
424 ARTHRITIS INFECTIVE 49 0.0106
425 PYELONEPHRITIS 91 0.0105
426 FURUNCLE 83 0.0105
427 B-CELL LYMPHOMA 35 0.0103
428 PAIN 6322 0.0103
429 SECRETION DISCHARGE 128 0.0102
430 BRONCHITIS 756 0.0102
431 DECREASED APPETITE 2366 0.0102
432 HERPES VIRUS INFECTION 58 0.0101
433 BILE DUCT STONE 32 0.0101
434 HEPATIC CYST 34 0.0100
435 GASTROOESOPHAGEAL REFLUX DISEASE 805 0.0100
436 DRUG EFFECT DECREASED 538 0.0100
437 GASTROENTERITIS 145 0.0099
438 CHEST PAIN 1839 0.0099
439 SKIN DISORDER 330 0.0099
440 MUSCLE SPASMS 1812 0.0099
441 HEPATIC FUNCTION ABNORMAL 367 0.0098
442 OESOPHAGEAL CANDIDIASIS 39 0.0098
443 SARS-COV-2 TEST POSITIVE 129 0.0098
444 DEVICE MALFUNCTION 679 0.0097
445 LYMPHOMA 149 0.0096
446 ANKYLOSING SPONDYLITIS 127 0.0096
447 RED CELL DISTRIBUTION WIDTH INCREASED 40 0.0096
448 PARAESTHESIA 1506 0.0096
449 PRODUCT USE IN UNAPPROVED INDICATION 2368 0.0095
450 INJECTION SITE REACTION 656 0.0095
451 ARTHRITIS BACTERIAL 39 0.0095
452 PAIN IN EXTREMITY 2799 0.0095
453 TOOTH INFECTION 125 0.0095
454 ARTHROPOD BITE 70 0.0094
455 STAPHYLOCOCCAL INFECTION 309 0.0094
456 CARPAL TUNNEL SYNDROME 131 0.0093
457 PRODUCT TEMPERATURE EXCURSION ISSUE 48 0.0093
458 PHARYNGITIS STREPTOCOCCAL 101 0.0093
459 PRURITUS 3580 0.0093
460 OEDEMA PERIPHERAL 1135 0.0093
461 PYREXIA 3201 0.0092
462 ESCHERICHIA INFECTION 76 0.0092
463 LIVER FUNCTION TEST ABNORMAL 267 0.0092
464 PANCREATITIS 485 0.0092
465 VULVOVAGINAL MYCOTIC INFECTION 36 0.0091
466 NONSPECIFIC REACTION 50 0.0091
467 NEPHROLITHIASIS 417 0.0091
468 VASCULAR DEVICE INFECTION 41 0.0090
469 SYMPTOM RECURRENCE 54 0.0090
470 HERPES ZOSTER 518 0.0090
471 HAEMORRHAGIC DIATHESIS 32 0.0090
472 INFLUENZA 999 0.0089
473 FATIGUE 6966 0.0089
474 HEPATOCELLULAR CARCINOMA 68 0.0089
475 WOUND SECRETION 35 0.0089
476 SKIN LESION 245 0.0089
477 POLYP 58 0.0088
478 SARCOIDOSIS 42 0.0088
479 ANGINA PECTORIS 253 0.0088
480 FAECES SOFT 64 0.0088
481 DRUG EFFECT INCOMPLETE 319 0.0088
482 CHOLELITHIASIS 288 0.0088
483 BOWEL MOVEMENT IRREGULARITY 67 0.0087
484 OSTEOMYELITIS 158 0.0087
485 INTRACRANIAL ANEURYSM 35 0.0087
486 RASH PRURITIC 470 0.0087
487 PULMONARY TUBERCULOSIS 37 0.0087
488 MALAISE 3797 0.0086
489 IMMUNE SYSTEM DISORDER 114 0.0086
490 VIRAL UPPER RESPIRATORY TRACT INFECTION 41 0.0086
491 COLON CANCER 128 0.0086
492 HEADACHE 5377 0.0086
493 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 610 0.0086
494 PREMATURE LABOUR 48 0.0085
495 SPINAL STENOSIS 35 0.0085
496 CERVIX CARCINOMA 33 0.0084
497 RHINITIS 68 0.0084
498 SHOULDER OPERATION 36 0.0084
499 GASTRIC DISORDER 287 0.0084
500 CHOLECYSTECTOMY 95 0.0083
501 STAPHYLOCOCCAL BACTERAEMIA 36 0.0083
502 INSOMNIA 2197 0.0082
503 EYE INFECTION 92 0.0081
504 HEPATITIS B 49 0.0081
505 THERAPY CESSATION 415 0.0081
506 LUNG INFECTION 125 0.0080
507 GAIT DISTURBANCE 1535 0.0080
508 HERNIA 155 0.0080
509 DIVERTICULUM INTESTINAL 35 0.0080
510 ABDOMINAL DISTENSION 833 0.0080
511 ORAL CANDIDIASIS 105 0.0080
512 INTENTIONAL DOSE OMISSION 227 0.0080
513 CONGESTIVE CARDIOMYOPATHY 33 0.0079
514 POOR QUALITY DRUG ADMINISTERED 51 0.0079
515 MALNUTRITION 88 0.0079
516 INSURANCE ISSUE 120 0.0078
517 VISUAL IMPAIRMENT 961 0.0077
518 DEPRESSION 1762 0.0077
519 IMMUNOSUPPRESSION 68 0.0077
520 ANAL INCONTINENCE 69 0.0077
521 NEOPLASM 88 0.0076
522 JOINT INJURY 163 0.0076
523 LYMPHADENOPATHY 270 0.0076
524 WHITE BLOOD CELL COUNT INCREASED 292 0.0076
525 BLOOD PRESSURE DIASTOLIC INCREASED 35 0.0076
526 LABORATORY TEST ABNORMAL 223 0.0075
527 BLOOD PRESSURE SYSTOLIC INCREASED 146 0.0075
528 VITAMIN D DEFICIENCY 73 0.0075
529 ABDOMINAL TENDERNESS 37 0.0074
530 IMMUNODEFICIENCY 111 0.0074
531 DIARRHOEA 4806 0.0074
532 IMPAIRED QUALITY OF LIFE 107 0.0074
533 POOR QUALITY PRODUCT ADMINISTERED 78 0.0074
534 THYROID CANCER 89 0.0074
535 HERPES SIMPLEX 48 0.0074
536 DECREASED IMMUNE RESPONSIVENESS 72 0.0073
537 DEVICE PHYSICAL PROPERTY ISSUE 56 0.0073
538 VOMITING 3427 0.0073
539 APHASIA 220 0.0073
540 ABDOMINAL HERNIA 33 0.0072
541 MENINGITIS 48 0.0072
542 BLOOD IRON DECREASED 85 0.0072
543 BREAST MASS 48 0.0071
544 DEVICE RELATED INFECTION 110 0.0071
545 PLEURISY 42 0.0071
546 FUNGAL INFECTION 235 0.0070
547 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 67 0.0070
548 HEPATIC ENZYME ABNORMAL 35 0.0070
549 KNEE OPERATION 69 0.0070
550 CANDIDA INFECTION 118 0.0070
551 HOSPITALISATION 1065 0.0069
552 CATARACT 412 0.0069
553 PEMPHIGOID 52 0.0069
554 SKIN MASS 46 0.0069
555 GASTROENTERITIS VIRAL 124 0.0069
556 ORAL HERPES 134 0.0069
557 CYST 85 0.0068
558 PULMONARY MASS 102 0.0068
559 HIP SURGERY 37 0.0068
560 WEIGHT DECREASED 1898 0.0068
561 TRANSAMINASES INCREASED 151 0.0068
562 RENAL CELL CARCINOMA 33 0.0067
563 ALANINE AMINOTRANSFERASE INCREASED 413 0.0067
564 ABNORMAL FAECES 55 0.0067
565 INFLUENZA LIKE ILLNESS 549 0.0067
566 SPINAL PAIN 78 0.0067
567 NEOPLASM MALIGNANT 442 0.0066
568 FEELING HOT 406 0.0066
569 GASTROINTESTINAL CARCINOMA 60 0.0066
570 ILEUS 82 0.0066
571 TENDON DISORDER 43 0.0066
572 MASS 92 0.0066
573 PRODUCT PRESCRIBING ERROR 154 0.0065
574 POST PROCEDURAL COMPLICATION 124 0.0065
575 TENDERNESS 67 0.0064
576 CHOLECYSTITIS 76 0.0064
577 URINARY TRACT INFECTION 1088 0.0064
578 LARGE INTESTINE POLYP 44 0.0063
579 ANKLE FRACTURE 98 0.0063
580 ANAPHYLACTIC REACTION 348 0.0063
581 VIRAL INFECTION 209 0.0063
582 SKIN EXFOLIATION 528 0.0063
583 SKIN LACERATION 68 0.0062
584 FOETAL EXPOSURE DURING PREGNANCY 507 0.0062
585 OVARIAN CYST 62 0.0062
586 CORONAVIRUS INFECTION 41 0.0062
587 RHINORRHOEA 400 0.0062
588 AUTOIMMUNE HEPATITIS 43 0.0062
589 CHOLECYSTITIS ACUTE 35 0.0062
590 ASPARTATE AMINOTRANSFERASE INCREASED 328 0.0062
591 GENERALISED ERYTHEMA 35 0.0061
592 ASTHENIA 2284 0.0061
593 CONCUSSION 47 0.0061
594 ABORTION SPONTANEOUS 243 0.0061
595 LARGE INTESTINE PERFORATION 42 0.0060
596 HEPATITIS C 73 0.0060
597 SKIN WARM 35 0.0060
598 COVID-19 1055 0.0060
599 HYPERKERATOSIS 33 0.0060
600 TREATMENT NONCOMPLIANCE 327 0.0060
601 INCONTINENCE 63 0.0060
602 ADRENAL INSUFFICIENCY 72 0.0059
603 FLUID RETENTION 300 0.0059
604 GENERAL PHYSICAL CONDITION ABNORMAL 40 0.0059
605 QUALITY OF LIFE DECREASED 79 0.0059
606 DYSARTHRIA 221 0.0059
607 UROSEPSIS 54 0.0058
608 MUSCULOSKELETAL DISORDER 111 0.0058
609 ANXIETY 1642 0.0058
610 PRODUCT COMPLAINT 146 0.0058
611 UTERINE CANCER 46 0.0057
612 NAUSEA 4513 0.0057
613 VASCULITIS 66 0.0057
614 LUNG NEOPLASM MALIGNANT 232 0.0056
615 SEPSIS 628 0.0056
616 DIZZINESS 2792 0.0056
617 DERMATITIS 117 0.0056
618 DYSPNOEA 3146 0.0056
619 TRANSIENT ISCHAEMIC ATTACK 186 0.0055
620 PRODUCT DISTRIBUTION ISSUE 51 0.0055
621 HAEMORRHOIDS 107 0.0055
622 SKIN REACTION 77 0.0055
623 BRAIN NEOPLASM 50 0.0054
624 SCAB 62 0.0054
625 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 298 0.0054
626 DUODENAL ULCER 38 0.0054
627 NERVE COMPRESSION 49 0.0053
628 NERVE INJURY 59 0.0053
629 APPETITE DISORDER 35 0.0053
630 PAPULE 37 0.0052
631 COVID-19 PNEUMONIA 62 0.0052
632 PRODUCT ADMINISTRATION ERROR 106 0.0052
633 BACTERAEMIA 62 0.0052
634 CEREBROVASCULAR ACCIDENT 884 0.0052
635 PROCEDURAL COMPLICATION 40 0.0052
636 GOUT 92 0.0051
637 CHEST DISCOMFORT 524 0.0051
638 TACHYCARDIA 454 0.0051
639 PRODUCT QUALITY ISSUE 694 0.0051
640 GASTROINTESTINAL PAIN 56 0.0051
641 ANGINA UNSTABLE 33 0.0051
642 JOINT EFFUSION 35 0.0051
643 SPINAL OPERATION 61 0.0049
644 CYTOMEGALOVIRUS INFECTION 82 0.0049
645 PRODUCT DISPENSING ERROR 107 0.0049
646 EPISTAXIS 367 0.0049
647 OROPHARYNGEAL PAIN 454 0.0049
648 CAESAREAN SECTION 57 0.0049
649 COMPLICATION ASSOCIATED WITH DEVICE 71 0.0049
650 DEVICE LEAKAGE 212 0.0049
651 BACTERIAL INFECTION 91 0.0049
652 GAMMA-GLUTAMYLTRANSFERASE INCREASED 108 0.0049
653 THERAPY PARTIAL RESPONDER 76 0.0049
654 MOUTH ULCERATION 102 0.0048
655 PAIN OF SKIN 130 0.0048
656 GALLBLADDER DISORDER 86 0.0048
657 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
658 PRODUCT CONTAINER ISSUE 41 0.0048
659 SPLENOMEGALY 56 0.0048
660 CARDIAC OPERATION 41 0.0048
661 PANCREATITIS ACUTE 107 0.0048
662 SKIN FISSURES 93 0.0048
663 BREAST CANCER 443 0.0047
664 HYPERAESTHESIA 39 0.0047
665 ABNORMAL LOSS OF WEIGHT 32 0.0047
666 PNEUMONIA BACTERIAL 41 0.0045
667 LEUKAEMIA 42 0.0044
668 NODULE 58 0.0044
669 ABDOMINAL PAIN LOWER 112 0.0044
670 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
671 UTERINE LEIOMYOMA 32 0.0044
672 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 228 0.0044
673 BLOOD DISORDER 35 0.0044
674 AORTIC ANEURYSM 33 0.0043
675 NEUTROPHIL COUNT INCREASED 44 0.0043
676 SLEEP APNOEA SYNDROME 82 0.0043
677 PHARYNGEAL SWELLING 42 0.0043
678 BLOOD ALBUMIN DECREASED 34 0.0043
679 HYPOALBUMINAEMIA 33 0.0042
680 BODY TEMPERATURE INCREASED 86 0.0042
681 MYASTHENIA GRAVIS 34 0.0042
682 DIABETES MELLITUS 319 0.0042
683 TOOTH EXTRACTION 52 0.0042
684 THROAT TIGHTNESS 112 0.0041
685 THERAPEUTIC RESPONSE SHORTENED 136 0.0041
686 ERYTHEMA 840 0.0041
687 FOOT FRACTURE 77 0.0041
688 FALL 1346 0.0040
689 SPINAL DISORDER 37 0.0039
690 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
691 LIMB INJURY 105 0.0039
692 ACUTE CORONARY SYNDROME 32 0.0039
693 ACNE 292 0.0038
694 BACK PAIN 891 0.0038
695 HYPOKINESIA 55 0.0038
696 LEUKOPENIA 189 0.0038
697 HEPATOMEGALY 37 0.0038
698 OPTIC NEURITIS 34 0.0037
699 PHOTOSENSITIVITY REACTION 61 0.0037
700 OVARIAN CANCER 34 0.0037
701 HEPATOTOXICITY 82 0.0037
702 WRIST FRACTURE 44 0.0037
703 PHOTOPHOBIA 69 0.0037
704 THERAPY INTERRUPTED 262 0.0037
705 CONJUNCTIVITIS 68 0.0037
706 BLOOD CREATININE INCREASED 236 0.0036
707 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
708 ILLNESS 368 0.0036
709 DEVICE OCCLUSION 50 0.0035
710 LYMPHOPENIA 50 0.0035
711 PROSTATE CANCER 281 0.0035
712 ISCHAEMIC STROKE 62 0.0035
713 ASPIRATION 38 0.0035
714 BREAST CANCER STAGE I 32 0.0034
715 BLOOD TRIGLYCERIDES INCREASED 61 0.0034
716 INCORRECT DOSE ADMINISTERED 787 0.0034
717 SCAR 59 0.0034
718 ACCIDENT 41 0.0034
719 BLOOD PRESSURE INCREASED 523 0.0034
720 PROSTATIC SPECIFIC ANTIGEN INCREASED 47 0.0034
721 HALLUCINATION, AUDITORY 54 0.0034
722 MYALGIA 573 0.0034
723 DEMENTIA 94 0.0034
724 BODY TEMPERATURE DECREASED 33 0.0033
725 GASTRITIS 88 0.0033
726 LIGAMENT SPRAIN 33 0.0033
727 BLADDER DISORDER 33 0.0033
728 TENDON RUPTURE 41 0.0033
729 COUGH 927 0.0033
730 MUSCULOSKELETAL CHEST PAIN 51 0.0033
731 UNEVALUABLE EVENT 249 0.0033
732 NEURALGIA 80 0.0033
733 ECZEMA 172 0.0033
734 MYOCARDIAL INFARCTION 571 0.0033
735 SYNCOPE 326 0.0033
736 PREMATURE BABY 98 0.0033
737 PALPITATIONS 381 0.0032
738 PARANOIA 56 0.0032
739 HYPERSOMNIA 93 0.0032
740 PERITONITIS 67 0.0032
741 DYSPHAGIA 306 0.0032
742 GASTRIC ULCER 61 0.0032
743 INTERSTITIAL LUNG DISEASE 155 0.0032
744 BEDRIDDEN 42 0.0032
745 CARDIOMYOPATHY 47 0.0032
746 HYPERTHYROIDISM 46 0.0032
747 DENTAL CARIES 35 0.0032
748 PNEUMOTHORAX 50 0.0031
749 SWELLING FACE 205 0.0031
750 SUBARACHNOID HAEMORRHAGE 32 0.0031
751 SEPTIC SHOCK 136 0.0031
752 NASAL CONGESTION 183 0.0031
753 VERTIGO 189 0.0031
754 HAEMORRHAGE 322 0.0031
755 MULTIPLE SCLEROSIS 147 0.0031
756 SCRATCH 32 0.0030
757 NERVOUS SYSTEM DISORDER 94 0.0030
758 INJURY ASSOCIATED WITH DEVICE 61 0.0030
759 BURNING SENSATION 210 0.0030
760 ACUTE MYOCARDIAL INFARCTION 88 0.0030
761 DRUG EFFECT LESS THAN EXPECTED 44 0.0030
762 POLYNEUROPATHY 35 0.0029
763 RIB FRACTURE 60 0.0029
764 ACUTE MYELOID LEUKAEMIA 45 0.0029
765 MYOCARDITIS 33 0.0029
766 SEIZURE 331 0.0029
767 DEEP VEIN THROMBOSIS 186 0.0029
768 UPPER LIMB FRACTURE 57 0.0029
769 PRODUCT USE COMPLAINT 45 0.0029
770 BLOOD URINE PRESENT 54 0.0028
771 DISEASE RECURRENCE 135 0.0028
772 PLATELET COUNT INCREASED 37 0.0028
773 RASH ERYTHEMATOUS 135 0.0028
774 PULMONARY EMBOLISM 267 0.0028
775 MENTAL DISORDER 122 0.0028
776 DERMATITIS ALLERGIC 35 0.0028
777 LOSS OF CONSCIOUSNESS 355 0.0028
778 THROMBOSIS 221 0.0027
779 HEPATIC CANCER 66 0.0027
780 IMPAIRED WORK ABILITY 58 0.0027
781 BLOOD TEST ABNORMAL 38 0.0027
782 PARAESTHESIA ORAL 39 0.0027
783 HIATUS HERNIA 35 0.0027
784 OSTEOPENIA 41 0.0027
785 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 543 0.0027
786 DEAFNESS 70 0.0027
787 TOOTH DISORDER 59 0.0027
788 ROTATOR CUFF SYNDROME 34 0.0026
789 HEAD INJURY 83 0.0026
790 BRAIN OEDEMA 33 0.0026
791 SKIN DISCOLOURATION 120 0.0026
792 DRUG RESISTANCE 67 0.0026
793 INJECTION SITE HAEMORRHAGE 208 0.0026
794 ANAPHYLACTIC SHOCK 67 0.0026
795 SPINAL FRACTURE 52 0.0026
796 PRURITUS GENERALISED 56 0.0026
797 THERAPEUTIC RESPONSE UNEXPECTED 116 0.0026
798 PULMONARY CONGESTION 34 0.0026
799 CEREBRAL INFARCTION 63 0.0026
800 RENAL DISORDER 120 0.0026
801 PANCREATIC CARCINOMA 74 0.0026
802 SWOLLEN TONGUE 80 0.0026
803 FLATULENCE 145 0.0026
804 POOR QUALITY SLEEP 55 0.0026
805 SENSORY DISTURBANCE 41 0.0026
806 PRODUCT PHYSICAL ISSUE 51 0.0025
807 INTRAOCULAR PRESSURE INCREASED 32 0.0025
808 MUSCULOSKELETAL DISCOMFORT 43 0.0025
809 DEHYDRATION 332 0.0025
810 HIP FRACTURE 80 0.0025
811 LETHARGY 143 0.0025
812 INJECTION SITE RASH 76 0.0025
813 EYE SWELLING 92 0.0025
814 ANAEMIA 470 0.0025
815 INCORRECT ROUTE OF DRUG ADMINISTRATION 88 0.0025
816 RASH MACULAR 86 0.0025
817 RENAL IMPAIRMENT 206 0.0024
818 FLUSHING 248 0.0024
819 PRODUCTIVE COUGH 116 0.0024
820 THROAT IRRITATION 109 0.0024
821 MYELODYSPLASTIC SYNDROME 35 0.0024
822 DEVICE USE ERROR 84 0.0024
823 ASCITES 71 0.0024
824 DEPRESSED MOOD 127 0.0024
825 EOSINOPHILIA 42 0.0024
826 RASH GENERALISED 62 0.0024
827 LIMB DISCOMFORT 74 0.0024
828 ACUTE RESPIRATORY FAILURE 46 0.0024
829 PNEUMONITIS 65 0.0024
830 COLD SWEAT 42 0.0024
831 VISION BLURRED 327 0.0024
832 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
833 DIABETES MELLITUS INADEQUATE CONTROL 42 0.0024
834 PSYCHOTIC DISORDER 70 0.0024
835 DRY SKIN 316 0.0024
836 INCORRECT DOSE ADMINISTERED BY DEVICE 62 0.0024
837 INJECTION SITE SWELLING 181 0.0024
838 ATRIAL FIBRILLATION 226 0.0023
839 THROMBOCYTOPENIA 256 0.0023
840 GASTRIC CANCER 57 0.0022
841 PANIC ATTACK 82 0.0022
842 HAEMATURIA 77 0.0022
843 APHONIA 31 0.0022
844 MUCOSAL INFLAMMATION 58 0.0022
845 BLINDNESS 90 0.0022
846 PROCEDURAL PAIN 61 0.0022
847 BLINDNESS UNILATERAL 31 0.0022
848 MIDDLE INSOMNIA 41 0.0022
849 HYPERHIDROSIS 282 0.0022
850 BLOOD POTASSIUM DECREASED 65 0.0022
851 EYE DISORDER 71 0.0022
852 ANGIOEDEMA 95 0.0021
853 PRESYNCOPE 52 0.0021
854 TUBULOINTERSTITIAL NEPHRITIS 40 0.0021
855 CARDIAC FAILURE 171 0.0021
856 DYSSTASIA 62 0.0021
857 HOT FLUSH 160 0.0021
858 MOVEMENT DISORDER 68 0.0021
859 TOOTHACHE 38 0.0021
860 LEUKOCYTOSIS 37 0.0020
861 CHILLS 239 0.0020
862 HAEMOGLOBIN DECREASED 209 0.0020
863 HEAD DISCOMFORT 36 0.0020
864 BONE DISORDER 37 0.0020
865 DYSPHONIA 118 0.0020
866 CARDIOVASCULAR DISORDER 51 0.0020
867 RASH PAPULAR 45 0.0020
868 FRACTURE 38 0.0020
869 HYPOTHYROIDISM 64 0.0020
870 CONSTIPATION 434 0.0020
871 FEELING ABNORMAL 475 0.0020
872 INJECTION SITE PAIN 600 0.0020
873 PLASMA CELL MYELOMA 76 0.0019
874 NEUROPATHY PERIPHERAL 185 0.0019
875 HEART RATE INCREASED 192 0.0019
876 DRUG PRESCRIBING ERROR 37 0.0019
877 INTENTIONAL PRODUCT MISUSE 168 0.0019
878 INJECTION SITE BRUISING 153 0.0019
879 BLOOD PRESSURE FLUCTUATION 46 0.0019
880 MUSCLE TWITCHING 44 0.0019
881 THIRST 34 0.0019
882 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
883 ERECTILE DYSFUNCTION 48 0.0019
884 OSTEONECROSIS 61 0.0019
885 DIPLOPIA 48 0.0018
886 FAECES DISCOLOURED 40 0.0018
887 DEVICE USE ISSUE 32 0.0018
888 HEPATIC FAILURE 55 0.0018
889 BLOOD PRESSURE ABNORMAL 36 0.0018
890 PALLOR 49 0.0018
891 HYPOKALAEMIA 82 0.0018
892 INJECTION SITE ERYTHEMA 220 0.0018
893 HEART RATE IRREGULAR 40 0.0018
894 CEREBRAL HAEMORRHAGE 63 0.0018
895 DRY EYE 87 0.0017
896 LACRIMATION INCREASED 52 0.0017
897 EXPIRED PRODUCT ADMINISTERED 57 0.0017
898 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
899 RENAL CANCER 81 0.0017
900 PRODUCT PRESCRIBING ISSUE 37 0.0017
901 SUICIDAL IDEATION 155 0.0017
902 CARDIAC DISORDER 158 0.0017
903 SKIN BURNING SENSATION 119 0.0017
904 BLADDER CANCER 97 0.0016
905 PERICARDIAL EFFUSION 38 0.0016
906 PLEURAL EFFUSION 100 0.0016
907 BONE PAIN 96 0.0016
908 INJECTION SITE PRURITUS 109 0.0016
909 ARRHYTHMIA 77 0.0016
910 PRODUCT AVAILABILITY ISSUE 37 0.0016
911 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
912 LIP SWELLING 54 0.0016
913 HAEMATOMA 42 0.0016
914 CARDIAC FAILURE CONGESTIVE 129 0.0016
915 MOOD SWINGS 49 0.0015
916 SKIN IRRITATION 69 0.0015
917 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
918 DYSURIA 55 0.0015
919 HYPOACUSIS 64 0.0015
920 JAUNDICE 40 0.0015
921 RESPIRATORY DISTRESS 41 0.0015
922 EYE PAIN 83 0.0015
923 INJECTION SITE MASS 54 0.0015
924 OVERDOSE 315 0.0015
925 NERVOUSNESS 76 0.0015
926 GASTROINTESTINAL HAEMORRHAGE 121 0.0014
927 DEATH 1245 0.0014
928 MENTAL IMPAIRMENT 35 0.0014
929 PNEUMONIA ASPIRATION 36 0.0014
930 RESPIRATORY FAILURE 105 0.0014
931 RED BLOOD CELL COUNT DECREASED 41 0.0014
932 TINNITUS 65 0.0014
933 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41 0.0014
934 SPEECH DISORDER 73 0.0014
935 RENAL FAILURE 185 0.0014
936 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 63 0.0013
937 FEELING COLD 37 0.0013
938 POLLAKIURIA 55 0.0013
939 HEART RATE DECREASED 46 0.0013
940 ENCEPHALOPATHY 32 0.0013
941 BLOOD BILIRUBIN INCREASED 35 0.0013
942 HYPOTENSION 259 0.0013
943 TREMOR 212 0.0013
944 DRUG DOSE OMISSION BY DEVICE 100 0.0013
945 PULMONARY OEDEMA 57 0.0013
946 FEMUR FRACTURE 39 0.0013
947 URINARY RETENTION 42 0.0013
948 CORONARY ARTERY DISEASE 38 0.0013
949 WHITE BLOOD CELL COUNT DECREASED 136 0.0013
950 HYPOPHAGIA 32 0.0013
951 EYE PRURITUS 42 0.0012
952 OCULAR HYPERAEMIA 59 0.0012
953 BLOOD PRESSURE DECREASED 82 0.0012
954 DISORIENTATION 48 0.0012
955 DYSPNOEA EXERTIONAL 45 0.0012
956 ACUTE KIDNEY INJURY 180 0.0012
957 BALANCE DISORDER 100 0.0012
958 EMOTIONAL DISTRESS 128 0.0011
959 DISEASE PROGRESSION 123 0.0010
960 SOMNOLENCE 196 0.0010
961 DYSGEUSIA 72 0.0010
962 COMA 46 0.0010
963 CHRONIC KIDNEY DISEASE 73 0.0010
964 BLOOD GLUCOSE INCREASED 180 0.0010
965 DISTURBANCE IN ATTENTION 48 0.0009
966 DEVICE BREAKAGE 36 0.0009
967 CARDIAC ARREST 73 0.0009
968 CARDIO-RESPIRATORY ARREST 36 0.0009
969 ACCIDENTAL OVERDOSE 31 0.0008
970 PLATELET COUNT DECREASED 89 0.0008
971 DERMATITIS ATOPIC 43 0.0008
972 HYPOGLYCAEMIA 38 0.0008
973 EYE IRRITATION 44 0.0008
974 WITHDRAWAL SYNDROME 32 0.0008
975 PANCYTOPENIA 42 0.0008
976 SUICIDE ATTEMPT 45 0.0007
977 OXYGEN SATURATION DECREASED 41 0.0007
978 BLOOD GLUCOSE DECREASED 33 0.0007
979 COGNITIVE DISORDER 32 0.0007
980 DRUG INTERACTION 106 0.0007
981 NEUTROPENIA 87 0.0006
982 IRRITABILITY 38 0.0006
983 HALLUCINATION 45 0.0006
984 PRODUCT SUBSTITUTION ISSUE 34 0.0006
985 NO ADVERSE EVENT 97 0.0005
986 AGITATION 39 0.0005
987 TOXICITY TO VARIOUS AGENTS 45 0.0003